Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J v. Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Stent patent infringement award of $324.4 mil. to Johnson & Johnson is set aside and a new damages trial has been ordered in Wilmington federal court, Boston Scientific announces March 28. However, the court upheld a portion of a December 2000 jury verdict that found the NIR stent, made by Medinol for Boston Scientific, infringed one claim of J&J's '762 Palmaz balloon expandable stent patent (1"The Gray Sheet" Dec. 18, 2000, p. 16). "Regardless of the outcome of the new damages trial, we plan on appealing any infringement judgment entered," Boston Scientific says...

You may also be interested in...

J&J v. Boston Scientific

Stent patent infringement verdict is set aside by Wilmington, Delaware federal court and a new trial will be held on the charge that Boston Scientific's NIR stent infringes a claim of a Johnson & Johnson patent. An initial damage award of $324.4 mil. to J&J was set aside in March (1"The Gray Sheet" April 1, 2002, In Brief). The judge also entered a "final judgement" that co-defendant Medtronic AVE's stents did not infringe the firm's patents "and stayed further proceedings in the [Boston Scientific] case until after any appeal of that judgment by J&J," Boston Scientific says. J&J plans to appeal...

J&J v. Medtronic

Wilmington, Delaware federal court sets aside stent patent infringement award of $271.1 mil. to Johnson & Johnson, Medtronic announces April 1. In a similar patent dispute between Boston Scientific and J&J, the same federal judge set aside a jury award of $324.4 mil. (1"The Gray Sheet" April 1, 2002, In Brief). J&J plans to appeal...

Boston Scientific Seeks To Have $324 Mil. J&J Stent Patent Award Set Aside

Boston Scientific says it may appeal a $324.4 mil. Johnson & Johnson stent patent suit damages award if it is unable to persuade the court to set aside the infringement verdict, arguing that the relevant patents were improperly obtained and are therefore unenforceable.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts